Arcturus Therapeutics Holdings
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.About ARCT
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.
ARCT Key Statistics
Stock Snapshot
Arcturus Therapeutics Holdings(ARCT) stock is priced at $7.25, giving the company a market capitalization of 205.93M. It carries a P/E multiple of -3.08.
During the trading session on 2026-03-05, Arcturus Therapeutics Holdings(ARCT) shares reached a daily high of $7.54 and a low of $7.12. At a current price of $7.25, the stock is +1.8% higher than the low and still -3.8% under the high.
Trading activity shows a volume of 565.23K, compared to an average daily volume of 487.14K.
The stock's 52-week range extends from a low of $5.85 to a high of $24.17.
The stock's 52-week range extends from a low of $5.85 to a high of $24.17.
ARCT News
Piper Sandler analyst Yasmeen Rahimi lowered the firm’s price target on Arcturus Therapeutics (ARCT) to $25 from $72 by removing the LUNAR-COVID Vaccine Global...
Reports Q4 revenue $7.2M, consensus $14.32M. “Arcturus continues to progress its rare disease therapeutic portfolio. We look forward to aligning with regulators...
Analyst ratings
75%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.